Apr 18, 2019 - Let's have a look at some of the highlights of J&J's (JNJ) first-quarter 2019 results.
Apr 17, 2019 - Johnson & Johnson continued its long streak of earnings beat and also outpaced revenue estimates. Though it raised the guidance for full-year sales growth, it tightened the earnings per share forecast.
Apr 17, 2019 - Markets closed higher on Tuesday as investors welcomed a spate of healthy first quarter earnings results.
Apr 16, 2019 - JNJ earnings call for the period ending March 31, 2019.
Apr 16, 2019 - Johnson & Johnson (NYSE:JNJ) Q1 2019 Earnings Conference Call April 16, 2019, 08:30 ET Company Participants Chris DelOrefice - VP, IR Joseph Wolk - EVP & CFO Jennifer Taubert - EVP & World
Apr 16, 2019 - Before the open, Johnson & Johnson (JNJ) issued upside Q1 results and reaffirmed its outlook for FY1
Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019 and raises 2019 guidance for operational sales and adjusted operational EPS growth. Shares up in pre-market trading.
Apr 16, 2019 - J&J (JNJ) beats estimates for both earnings and sales in the first quarter of 2019. Hikes 2019 guidance for operational sales and earnings growth. Shares up in pre-market trading.
Apr 16, 2019 - Johnson & Johnson (JNJ) Q1 results: Revenues: $20,021M (+0.1%); Consumer: $3,318M (-2.4%); Pharmaceuticals: $10,244M (+4.1%); Medical Devices: $6,459M (-4.6%).Net Income: $3,749M (-14.2%); EPS: $1
Apr 16, 2019 - Q1 Earnings To Watch For